Breaking News Instant updates and real-time market news.

2022-11-01 07:30:14 XERS Xeris Biopharma $1.61 / -0.05 (-3.02%) 07:30 11/01/22 11/01 07:30 11/01/22 07:30	Xeris Biopharma announces results of extended Recorlev study from Sonics Study Xeris Biopharma Holding announced that the European Journal of Endocrinology EJE published the extended evaluation results of the SONICS study or NCT01838551,evaluating longer-term effects of levoketoconazole on cortisol levels, biomarkers of Cushing's syndrome (CS) comorbidities, clinical signs and symptoms of CS, and quality of life.1 The manuscript also reports findings from pituitary adenoma imaging in the SONICS study..."The results from this extended evaluation of the SONICS study provide important new evidence in support of Recorlev and will help inform clinicians' decisions and individualization of medical therapy for patients with endogenous CS," said Dr. Ken Johnson, Senior Vice President, Global Development and Medical Affairs at Xeris. "I would like to extend our gratitude to all the investigators, study coordinators and patients who participated in the SONICS trial program. Their contributions are integral in our mission to improve outcomes for patients with this rare, debilitating, and life-threatening condition."

2022-11-01 07:30:14

XERS

Xeris Biopharma

$1.61 / -0.05 (-3.02%)

07:30

11/01/22

11/01

07:30

11/01/22

07:30

Xeris Biopharma announces results of extended Recorlev study from Sonics Study

Xeris Biopharma Holding announced that the European Journal of Endocrinology EJE published the extended evaluation results of the SONICS study or NCT01838551,evaluating longer-term effects of levoketoconazole on cortisol levels, biomarkers of Cushing's syndrome (CS) comorbidities, clinical signs and symptoms of CS, and quality of life.1 The manuscript also reports findings from pituitary adenoma imaging in the SONICS study..."The results from this extended evaluation of the SONICS study provide important new evidence in support of Recorlev and will help inform clinicians' decisions and individualization of medical therapy for patients with endogenous CS," said Dr. Ken Johnson, Senior Vice President, Global Development and Medical Affairs at Xeris. "I would like to extend our gratitude to all the investigators, study coordinators and patients who participated in the SONICS trial program. Their contributions are integral in our mission to improve outcomes for patients with this rare, debilitating, and life-threatening condition."

OTHER BREAKING NEWS FROM THE FLY

Options	Planet Labs PBC options imply 11.7% move in share price post-earnings » 13:34 03/29/23 03/29 13:34 03/29/23 13:34 PL Planet Labs $3.45 / +0.035 (+1.02%) Pre-earnings options… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options PL Planet Labs $3.45 / +0.035 (+1.02%) 03/22/23 Planet Labs awarded contract for hyperspectral capabilities by NRO 02/22/23 Planet and ASU team to build global scale solutions for sustainability 01/03/23 Planet Labs announces successful launch of 36 SuperDove satellites 12/16/22 Planet Labs rises 10.2% PL Planet Labs $3.45 / +0.035 (+1.02%) 01/23/23 Morgan Stanley Planet Labs initiated with an Equal Weight at Morgan Stanley 12/19/22 Northland Maxar deal sheds light on growing value of Planet Labs data, says Northland 11/08/22 Deutsche Bank Planet Labs initiated with a Buy at Deutsche Bank 09/13/22 Needham Planet Labs price target raised to $9 from $8 at Needham PL Planet Labs $3.45 / +0.035 (+1.02%) 12/14/22 Planet Labs raises FY23 revenue view to $188M-$192M from $182M-$190M 12/14/22 Planet Labs sees Q4 revenue $50M-$54M, consensus $51.2M 12/14/22 Planet Labs reports Q3 EPS (15c), consensus (17c) PL Planet Labs $3.45 / +0.035 (+1.02%) 02/03/23 Sell these stocks now, proven algorithm says 12/16/22 What You Missed On Wall Street On Friday 12/16/22 Sell these stocks now, proven algorithm says 12/16/22 What You Missed On Wall Street This Morning 17:00 Today Planet Labs - PL PL Planet Labs $3.45 / +0.035 (+1.02%) 12/14/22 Planet Labs PBC options imply 9.7% move in share price post-earnings
Recommendations	Bluebird Bio reaction to lovo-cel BLA delay 'overdone,' says Raymond James » 13:27 03/29/23 03/29 13:27 03/29/23 13:27 BLUE Bluebird Bio $3.15 / -1.155 (-26.86%) , CRSP Crispr Therapeutics $44.65 / +0.68 (+1.55%) , VRTX Vertex Pharmaceuticals $314.21 / +1.01 (+0.32%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options BLUE CRSP VRTX BLUE Bluebird Bio $3.15 / -1.155 (-26.86%) 01/18/23 Bluebird Bio falls 14% to $6.28 after 20M share offering of common stock 01/06/23 Bluebird Bio to sell second Zynteglo PRV for $95M 01/03/23 Bluebird Bio appoints Joseph Vittiglio, JD, chief business and legal officer 12/29/22 Bluebird Bio completes sale pf PRV to Argenx CRSP Crispr Therapeutics $44.65 / +0.68 (+1.55%) 08:16 Today Crispr Therapeutics announces departure of board member 03/27/23 Vertex Pharmaceuticals, Crispr Therapeutics enter CRISPR/Cas9 licensing pact 03/13/23 Crispr Therapeutics CFO Brendan Smith to depart, Raju Prasad to succeed 12/27/22 Cathie Wood's ARK Investment bought 10.8K shares of Crispr Therapeutics today VRTX Vertex Pharmaceuticals $314.21 / +1.01 (+0.32%) 03/27/23 Vertex Pharmaceuticals, Crispr Therapeutics enter CRISPR/Cas9 licensing pact 03/09/23 Vertex says FDA clears IND for VX-264 with potential to treat type 1 diabetes 03/09/23 Vertex says FDA clears IND for VX-264 with potential to treat type 1 diabetes 03/01/23 ImmunoGen announces license agreement with Vertex Pharmaceuticals BLUE CRSP VRTX BLUE Bluebird Bio $3.15 / -1.155 (-26.86%) 03/06/23 Baird Baird starts Bluebird at Outperform, sees lovo-cel beating estimates 03/06/23 Baird Bluebird Bio initiated with an Outperform at Baird 12/19/22 Morgan Stanley FDA removing lovo-cel partial hold a positive for Bluebird, says Morgan Stanley 09/27/22 Morgan Stanley Vertex exa-cel filing timeline 'better than feared,' says Morgan Stanley CRSP Crispr Therapeutics $44.65 / +0.68 (+1.55%) 03/21/23 Bernstein Crispr Therapeutics initiated with a Market Perform at Bernstein 03/18/23 Citi Crispr Therapeutics price target lowered to $55 from $63 at Citi 03/17/23 Bryan Garnier Crispr Therapeutics initiated with a Buy at Bryan Garnier 03/06/23 Baird Baird starts Crispr at Neutral with strong launch priced in VRTX Vertex Pharmaceuticals $314.21 / +1.01 (+0.32%) 07:38 Today Argus Vertex Pharmaceuticals price target raised to $350 from $340 at Argus 03/21/23 Bernstein Vertex Pharmaceuticals initiated with an Outperform at Bernstein 03/01/23 Guggenheim Immunogen confident in early Elahere launch, says Guggenheim 02/22/23 Chardan Crispr Therapeutics price target lowered to $123 from $153 at Chardan BLUE CRSP VRTX BLUE Bluebird Bio $3.15 / -1.155 (-26.86%) 07:07 Today Bluebird Bio reports Q4 EPS (38c), consensus (44c) 11/07/22 Bluebird Bio reports Q4 EPS (94c) vs, ($3.16) 11/07/22 Bluebird Bio reports Q4 EPS (94c) vs, ($3.16) CRSP Crispr Therapeutics $44.65 / +0.68 (+1.55%) 02/22/23 Crispr Therapeutics reports Q4 EPS ($1.41) vs. ($1.84) y/y VRTX Vertex Pharmaceuticals $314.21 / +1.01 (+0.32%) 02/07/23 Vertex Pharmaceuticals guides FY23 revenue $9.55B-$9.70B, consensus $9.6B 02/07/23 Vertex Pharmaceuticals reports Q4 EPS $3.76, consensus $3.51 02/07/23 Notable companies reporting after market close 10/27/22 Vertex Pharmaceuticals raises 2022 revenue to $8.8B-$8.9B from $8.6B-$8.9B 19 Jan VRTX VRTX Vertex Pharmaceuticals $314.21 / +1.01 (+0.32%) 02/07/23 Vertex keeps cystic fibrosis drug out of developing countries, NY Times reports BLUE VRTX BLUE Bluebird Bio $3.15 / -1.155 (-26.86%) 12:15 Today What You Missed On Wall Street This Morning 01/18/23 What You Missed On Wall Street On Wednesday 01/18/23 What You Missed On Wall Street This Morning 12/19/22 What You Missed On Wall Street On Monday VRTX Vertex Pharmaceuticals $314.21 / +1.01 (+0.32%) 03/21/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/09/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/30/22 What You Missed On Wall Street This Morning 12/19/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/03/23 The Future of Oncology Virtual Symposium 08:30 Today Bluebird Bio - BLUE BLUE CRSP VRTX BLUE Bluebird Bio $3.15 / -1.155 (-26.86%) 03/10/23 Bluebird Bio options imply 10.1% move in share price post-earnings 03/07/23 Bluebird Bio options imply 4.8% move in share price post-earnings 09/30/22 Bluebird Bio call volume above normal and directionally bullish CRSP Crispr Therapeutics $44.65 / +0.68 (+1.55%) 02/21/23 Crispr Therapeutics options imply 4.4% move in share price post-earnings 02/14/23 Crispr Therapeutics options imply 4.9% move in share price post-earnings 01/05/23 Crispr Therapeutics call volume above normal and directionally bullish VRTX Vertex Pharmaceuticals $314.21 / +1.01 (+0.32%) 02/07/23 Vertex options imply 3.7% move in share price post-earnings 11/28/22 Early notable gainers among liquid option names on November 28th
Conference/Events	Cronos Group to participate in a conference call with ROTH MKM » 13:24 03/29/23 03/29 13:24 03/29/23 13:24 CRON Cronos Group $1.92 / +0.025 (+1.32%) Beverage-Cannabis-Food… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events CRON Cronos Group $1.92 / +0.025 (+1.32%) 02/08/23 Cronos says Spinach is top-selling edible brand in Canada in January 12/19/22 Cronos Group receives notice of relinquishment of warrant by Altria Group 12/07/22 Cronos unveils new CBC product, Spinach FEELZ Day Trip Gummies 12/02/22 White House announces signing of medical marijuana research expansion act CRON Cronos Group $1.92 / +0.025 (+1.32%) 03/01/23 Canaccord Cronos Group price target lowered to C$4.25 from C$4.75 at Canaccord 11/09/22 Bernstein Two more states legalize cannabis, $3B added to TAM, says Bernstein 11/08/22 Canaccord Cronos Group price target lowered to C$4.75 from C$5 at Canaccord 11/01/22 Bernstein Cronos started with Market Perform on limited visibility at Bernstein CRON Cronos Group $1.92 / +0.025 (+1.32%) 02/28/23 Cronos Group reports Q3 EPS (21c), consensus (5c) 11/07/22 Cronos Group reports Q3 EPS (10c), consensus (6c) CRON Cronos Group $1.92 / +0.025 (+1.32%) 12/27/22 FDA explores regulating CBD in foods, supplements, WSJ reports 12/05/22 Defense bill with marijuana reform attached is delayed, Marijuana Moment says CRON Cronos Group $1.92 / +0.025 (+1.32%) 03/23/23 Here's What You Missed in Cannabis, Psychedelics This Week 03/16/23 Rising High: Exclusive talk with house of brands Carma HoldCo 03/09/23 Rising High: Exclusive talk with cannabinoid market research firm BDSA 03/02/23 Rising High: Exclusive talk with vertically-integrated MSO Greenlight 03/30/23 Cronos Group
General news	Treasury's $35 B 7-year sale was disappointing » 13:20 03/29/23 03/29 13:20 03/29/23 13:20 $ECON Economic Data / + Treasury's $35 B… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly Technical Analysis $ECON Economic Data / + 03/22/23 Senators Scott, Warren unveil bipartisan Fed oversight legislation 03/01/23 Einhorn says investors should be 'bearish on stocks and bullish on inflation' $ECON Economic Data / + $ECON Economic Data / + 03/08/23 Biden to propose 25% billionaire tax, Bloomberg says 03/08/23 Biden to propose 25% billionaire tax, Bloomberg says 03/07/23 Powell tells Congress data from January partly reversed softening trends 01/30/23 Fed likely to raise funds rate benchmark by quarter percentage point, WSJ says $ECON Economic Data / + 03/22/23 What You Missed On Wall Street On Wednesday 03/21/23 What You Missed On Wall Street On Tuesday 03/21/23 What You Missed On Wall Street This Morning 03/08/23 What You Missed On Wall Street On Wednesday $ECON Economic Data / + 03/22/23 Fed says 'additional policy firming may be appropriate'
Options	Virgin Orbit options imply 12.8% move in share price post-earnings » 13:19 03/29/23 03/29 13:19 03/29/23 13:19 VORB Virgin Orbit / + Pre-earnings options… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly VORB Virgin Orbit / + 03/22/23 Virgin Orbit confirms incremental resumption of operations 03/16/23 Virgin Orbit confirms operational pause amid discussions for funding 02/14/23 Virgin Orbit provides update on U.K. mission anomaly 02/03/23 Virgin Orbit, SatRev announce follow-on launch services agreement VORB Virgin Orbit / + 03/17/23 Canaccord Virgin Orbit rating, target put under review at Canaccord after operations halt 01/11/23 Canaccord Virgin Orbit price target lowered to $6 from $12 10/11/22 Credit Suisse Virgin Orbit initiated with Underperform on elevated cash burn at Credit Suisse 10/11/22 Credit Suisse Virgin Orbit initiated with an Underperform at Credit Suisse VORB Virgin Orbit / + 03/27/23 Virgin Orbit plans to extend employee furlough, Reuters reports 03/22/23 Virgin Orbit returning 'small' team to work Thursday, CNBC reports 03/22/23 Virgin Orbit nearing deal for $200M investment from Matthew Brown, Reuters says 03/16/23 Virgin Orbit in discussions over possible buyout, FT reports VORB Virgin Orbit / + 03/28/23 Fly Intel: Pre-market Movers 03/22/23 What You Missed On Wall Street This Morning 03/22/23 Fly Intel: Pre-market Movers 03/16/23 What You Missed On Wall Street On Thursday
Technical Analysis	NASDAQ market internals summary » 13:17 03/29/23 03/29 13:17 03/29/23 13:17 $NSD NASDAQ Market Internals / + Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals / + 12:17 Today NASDAQ market internals summary 11:17 Today NASDAQ market internals summary 10:17 Today NASDAQ market internals summary 03/28/23 NASDAQ market internals summary
Technical Analysis	NYSE market internals summary » 13:16 03/29/23 03/29 13:16 03/29/23 13:16 $NYE NYSE Market Internals / + Volume is average for… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals / + 12:16 Today NYSE market internals summary 11:16 Today NYSE market internals summary 10:16 Today NYSE market internals summary 03/28/23 NYSE market internals summary
Conference/Events	DA Davidson consumer products analyst to hold analyst/industry conference call » 13:15 03/29/23 03/29 13:15 03/29/23 13:15 WW WW $3.85 / -0.205 (-5.06%) , MED Medifast $97.87 / +0.595 (+0.61%) , PLNT Planet Fitness $75.72 / -0.27 (-0.36%) Consumer Products Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options WW PLNT WW WW $3.85 / -0.205 (-5.06%) 03/20/23 S&P announces changes to S&P 600 index at open on 3/20 03/06/23 WW to acquire Sequence for $132M in cash, stock 03/03/23 S&P announces changes to S&P 600 index at open on 3/20 11/30/22 WW announces departure of CFO Amy O'Keefe PLNT Planet Fitness $75.72 / -0.27 (-0.36%) 03/16/23 Planet Fitness signs technology agreement extension with ABC Fitness Solutions 01/09/23 Planet Fitness reports about 17M members as of December 31, 2022 12/12/22 Planet Fitness names Edward Hymes president, COO 11/30/22 Planet Fitness launches redesigned version of the Planet Fitness App WW MED PLNT WW WW $3.85 / -0.205 (-5.06%) 03/08/23 Craig-Hallum Craig-Hallum downgrades WW to Sell, sees stock outperformance as overreaction 03/08/23 DA Davidson WW price target raised to $9 from $6 at DA Davidson 03/08/23 Craig-Hallum WW downgraded to Sell from Hold at Craig-Hallum 11/08/22 DA Davidson WW price target lowered to $6 from $15 at DA Davidson MED Medifast $97.87 / +0.595 (+0.61%) 11/04/22 DA Davidson Medifast downgraded to Neutral from Buy at DA Davidson 09/13/22 DA Davidson Medifast among DA Davidson's 'high-conviction small cap ideas' 08/04/22 Jefferies Medifast downgraded at Jefferies after 'major' guidance disappointment 08/04/22 DA Davidson Medifast price target lowered to $278 from $352 at DA Davidson PLNT Planet Fitness $75.72 / -0.27 (-0.36%) 02/27/23 Cowen Planet Fitness price target raised to $92 from $90 at Cowen 02/24/23 Raymond James Planet Fitness price target raised to $95 from $92 at Raymond James 02/24/23 Baird Planet Fitness price target raised to $105 from $100 at Baird 02/16/23 DA Davidson Planet Fitness cut to Neutral at DA Davidson after 50% stock rally WW MED PLNT WW WW $3.85 / -0.205 (-5.06%) 03/06/23 WW sees Q1 revenue $235M, consensus $243.89M 03/06/23 WW reports Q4 EPS (46c), consensus 0c 11/03/22 WW sees 2022 revenue $1.04B, consensus $1.06B 11/03/22 WW reports Q3 EPS with items ($2.93), consensus 36c MED Medifast $97.87 / +0.595 (+0.61%) 02/21/23 Medifast sees Q1 EPS $1.75-$2.40, one estimate $3.26 02/21/23 Medifast reports Q4 EPS $3.70 vs. $2.91 y/y 11/04/22 Medifast cuts FY22 EPS view to $11.61-$13.05 from $12.70-$14.10 11/04/22 Medifast reports Q3 EPS $3.32 vs. $3.56 last year PLNT Planet Fitness $75.72 / -0.27 (-0.36%) 02/23/23 Planet Fitness sees FY23 adjusted EPS up 33%-36%, consensus $2.06 02/23/23 Planet Fitness reports Q4 adjusted EPS 53c, consensus 47c 02/22/23 Notable companies reporting before tomorrow's open 02/22/23 Notable companies reporting before tomorrow's open WW PLNT WW WW $3.85 / -0.205 (-5.06%) 03/06/23 WW buying digital health company Sequence, WSJ reports PLNT Planet Fitness $75.72 / -0.27 (-0.36%) 01/19/23 Planet Fitness received 'hundreds' of consumer complaints, says The Bear Cave WW MED PLNT WW WW $3.85 / -0.205 (-5.06%) 03/11/23 Buy/Sell: Wall Street's top 10 stock calls this week 03/08/23 What You Missed On Wall Street On Wednesday 03/08/23 What You Missed On Wall Street This Morning 03/08/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations MED Medifast $97.87 / +0.595 (+0.61%) 02/21/23 Fly Intel: After-Hours Movers PLNT Planet Fitness $75.72 / -0.27 (-0.36%) 02/23/23 Fly Intel: Pre-market Movers 02/16/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/19/23 What You Missed On Wall Street This Morning 01/09/23 Fly Intel: After-Hours Movers 05/01/23 Planet Fitness, Inc. 05/09/23 WW International Inc WW WW WW $3.85 / -0.205 (-5.06%) 03/06/23 Weight Watchers options imply 23.2% move in share price post-earnings
General news	7-year note auction » 13:10 03/29/23 03/29 13:10 03/29/23 13:10 $ECON Economic Data / + Total Amount: $35B, Rate:… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly Technical Analysis $ECON Economic Data / + 03/22/23 Senators Scott, Warren unveil bipartisan Fed oversight legislation 03/01/23 Einhorn says investors should be 'bearish on stocks and bullish on inflation' $ECON Economic Data / + $ECON Economic Data / + 03/08/23 Biden to propose 25% billionaire tax, Bloomberg says 03/08/23 Biden to propose 25% billionaire tax, Bloomberg says 03/07/23 Powell tells Congress data from January partly reversed softening trends 01/30/23 Fed likely to raise funds rate benchmark by quarter percentage point, WSJ says $ECON Economic Data / + 03/22/23 What You Missed On Wall Street On Wednesday 03/21/23 What You Missed On Wall Street On Tuesday 03/21/23 What You Missed On Wall Street This Morning 03/08/23 What You Missed On Wall Street On Wednesday $ECON Economic Data / + 03/22/23 Fed says 'additional policy firming may be appropriate'
Hot Stocks	Arko says 'riskless' to TravelCenters' holders for board to engage on proposal » 13:05 03/29/23 03/29 13:05 03/29/23 13:05 TA TravelCenters $86.16 / +0.095 (+0.11%) , ARKO Arko Corp. $8.48 / +0.235 (+2.85%) , BP BP $37.66 / +0.23 (+0.61%) ARKO Corp. (ARKO) issued… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options TA ARKO BP TA TravelCenters $86.16 / +0.095 (+0.11%) 03/28/23 TravelCenters confirms ARKO proposal not superior to BP transaction 03/27/23 ARKO urges Travel Centers board to consider acquisition proposal 02/16/23 BP Products North America to acquire TravelCenters of America for $1.3B in cash 02/15/23 White House announces progress for national network of EV chargers ARKO Arko Corp. $8.48 / +0.235 (+2.85%) 03/28/23 TravelCenters confirms ARKO proposal not superior to BP transaction 03/27/23 ARKO urges Travel Centers board to consider acquisition proposal 03/02/23 Arko Corp. closes 23rd acquisition, acquires assets of TEG 01/10/23 Arko Corp. announces CFO Bassell to retire BP BP $37.66 / +0.23 (+0.61%) 03/28/23 TravelCenters confirms ARKO proposal not superior to BP transaction 03/27/23 ARKO urges Travel Centers board to consider acquisition proposal 02/22/23 Texas Pacific Land, bpx energy reach long-term agreement 02/16/23 BP Products North America to acquire TravelCenters of America for $1.3B in cash TA ARKO BP TA TravelCenters $86.16 / +0.095 (+0.11%) 02/17/23 B. Riley TravelCenters downgraded to Neutral on buyout at B. Riley 02/17/23 Benchmark TravelCenters downgraded to Hold from Buy at Benchmark 02/17/23 BMO Capital TravelCenters price target raised to $86 from $60 at BMO Capital 02/17/23 B. Riley TravelCenters downgraded to Neutral from Buy at B. Riley ARKO Arko Corp. $8.48 / +0.235 (+2.85%) 03/10/23 BMO Capital Arko Corp. price target raised to $12 from $10 at BMO Capital 01/09/23 BMO Capital Arko Corp. price target lowered to $10 from $12 at BMO Capital 05/25/22 Wells Fargo Arko Corp. initiated with an Equal Weight at Wells Fargo BP BP $37.66 / +0.23 (+0.61%) 03/21/23 Morgan Stanley BP price target lowered to 605 GBp from 660 GBp at Morgan Stanley 02/24/23 JPMorgan BP price target raised to 585 GBp from 540 GBp at JPMorgan 02/23/23 Berenberg BP downgraded to Hold from Buy at Berenberg 02/17/23 BMO Capital TravelCenters price target raised to $86 from $60 at BMO Capital TA ARKO BP TA TravelCenters $86.16 / +0.095 (+0.11%) 02/28/23 TravelCenters reports Q4 EPS $3.14 vs 87c last year 11/01/22 TravelCenters reports Q3 EPS $2.49, consensus $2.67 ARKO Arko Corp. $8.48 / +0.235 (+2.85%) 02/27/23 Arko Corp. reports Q4 EPS 9c, consensus 9c 11/07/22 Arko Corp. reports Q3 diluted EPS 17c, consensus 29c BP BP $37.66 / +0.23 (+0.61%) 02/07/23 BP reports Q4 EPS $1.59, consensus $1.67 11/01/22 BP reports Q3 EPS $2.59, consensus $1.94 BP BP BP $37.66 / +0.23 (+0.61%) 03/23/23 BP considers buying control of solar power JV Lightsource BP, Reuters says 01/18/23 U.S. Energy Secretary warns GOP of oil bill risks, Reuters says 01/10/23 ExxonMobil led group develops1.3B barrel off shore Guyana field, AP reports 12/05/22 BP bets big on hydrogen as fuel of the future, Reuters reports TA BP TA TravelCenters $86.16 / +0.095 (+0.11%) 02/21/23 What You Missed This Week in EVs and Clean Energy 02/16/23 What You Missed On Wall Street On Thursday 02/16/23 What You Missed On Wall Street This Morning 11/23/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations BP BP $37.66 / +0.23 (+0.61%) 03/23/23 What You Missed On Wall Street This Morning 02/21/23 What You Missed This Week in EVs and Clean Energy 02/16/23 What You Missed On Wall Street On Thursday 02/16/23 What You Missed On Wall Street This Morning BP BP BP $37.66 / +0.23 (+0.61%) 03/24/23 Unusually active option classes on open March 24th 03/22/23 Unusually active option classes on open March 22nd 03/21/23 Unusually active option classes on open March 21st 02/15/23 Largest borrow rate increases among liquid names

Periodicals	Microsoft patched Bing vulnerability days before launch with AI, WSJ says » 13:04 03/29/23 03/29 13:04 03/29/23 13:04 MSFT Microsoft $279.51 / +4.23 (+1.54%) Microsoft patched a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MSFT Microsoft $279.51 / +4.23 (+1.54%) 03/28/23 Google teams with AI firm Replit to aid generative AI for software development 03/27/23 Microsoft, Internews, USAID to develop Media Viability Accelerator 03/24/23 CMA 'narrows scope of concerns' in Microsoft-Activision review 03/22/23 Microsoft, CarbonCapture reach carbon removal credits agreement MSFT Microsoft $279.51 / +4.23 (+1.54%) 07:12 Today JPMorgan Microsoft 'best house' in 'deteriorating neighborhood,' says JPMorgan 06:46 Today KeyBanc Microsoft price target raised to $316 from $270 at KeyBanc 03/28/23 BMO Capital Microsoft price target raised to $305 from $265 at BMO Capital 03/26/23 Citi Activision Blizzard price target raised to $91 from $88 at Citi MSFT Microsoft $279.51 / +4.23 (+1.54%) 01/24/23 Microsoft reports Q2 adjusted EPS $2.32, consensus $2.29 01/24/23 Notable companies reporting after market close 10/25/22 Microsoft sees FX decreasing total revenue growth by 5% in FY23 10/25/22 Microsoft reports Q1 EPS $2.35, consensus $2.30 MSFT Microsoft $279.51 / +4.23 (+1.54%) 03/28/23 Microsoft offers to revise cloud practices to avoid EU probe, Reuters says 03/28/23 Congress members claim Sony unfairly harming Xbox in Japan, Axios reports 03/28/23 Microsoft, OVH near settlement on EU antitrust complaints, Bloomberg says 03/28/23 Microsoft's GitHub cuts engineering team in India, TechCrunch reports MSFT Microsoft $279.51 / +4.23 (+1.54%) 03/28/23 What You Missed On Wall Street On Tuesday 03/28/23 What You Missed On Wall Street This Morning 03/28/23 What You Missed This Week in Video Games 03/27/23 What You Missed On Wall Street On Monday 03/30/23 Enterprise IT 04/17/23 Software & Internet 04/24/23 RSA Conference 2023 MSFT Microsoft $279.51 / +4.23 (+1.54%) 03/17/23 Early notable gainers among liquid option names on March 17th 03/17/23 Unusually active option classes on open March 17th 03/07/23 Microsoft put buyer realizes 3% same-day gains 02/13/23 Early notable gainers among liquid option names on February 13th
Options	Restoration Hardware options imply 7.4% move in share price post-earnings » 13:04 03/29/23 03/29 13:04 03/29/23 13:04 RH RH $242.01 / +0.885 (+0.37%) Pre-earnings options… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options RH RH $242.01 / +0.885 (+0.37%) 02/03/23 RH says certain financial statements 'should no longer be relied upon' 02/03/23 RH sees FY22 revenue growth at low end of prior range of (3.5%)-(4.5%) 12/08/22 RH says Q3 gross margin contracted 50bps 12/08/22 RH to acquire Dmitriy & Co RH RH $242.01 / +0.885 (+0.37%) 03/27/23 Wedbush RH price target lowered to $245 from $335 at Wedbush 03/06/23 Jefferies RH cut to Hold at Jefferies with luxury housing market 'struggling to stabilize' 03/06/23 Jefferies RH downgraded to Hold from Buy at Jefferies 02/07/23 Barclays Barclays sees a 'reset' in U.S. retail but 'not a recession yet' RH RH $242.01 / +0.885 (+0.37%) 12:44 Today Notable companies reporting after market close 12/08/22 RH narrow FY22 revenue growth view to down 4.5% to down 3.5% 12/08/22 RH reports Q3 EPS $5.67, consensus $4.70 12/08/22 Notable companies reporting after market close RH RH $242.01 / +0.885 (+0.37%) 03/06/23 What You Missed On Wall Street On Monday 03/06/23 What You Missed On Wall Street This Morning 03/06/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/06/23 What You Missed On Wall Street On Monday 17:00 Today RH - RH RH RH $242.01 / +0.885 (+0.37%) 02/08/23 Largest borrow rate increases among liquid names 12/08/22 Restoration Hardware options imply 7.8% move in share price post-earnings 10/24/22 Restoration Hardware put volume heavy and directionally bearish
Hot Stocks	Apple WWDC to run from June 5-9 » 13:01 03/29/23 03/29 13:01 03/29/23 13:01 AAPL Apple $159.91 / +2.235 (+1.42%) Apple stated in a post to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options AAPL Apple $159.91 / +2.235 (+1.42%) 03/28/23 Affirm down 5% after Apple launches Pay Later offering in U.S. 03/28/23 Apple introduces Apple Pay Later, consumers able to pay for purchases over time 03/28/23 Apple launches Apple Music Classical standalone app 03/24/23 Apple COO sells $30.0M in common stock AAPL Apple $159.91 / +2.235 (+1.42%) 03/28/23 Mizuho Apple 'Pay Later' should already be reflected in Affirm price, says Mizuho 03/28/23 Barclays Apple advertising on own apps is underappreciated, says Barclays 03/21/23 Morgan Stanley Microsoft app store longer-term Apple risk 'worth watching,' says Morgan Stanley 03/16/23 Susquehanna Qualcomm upgraded at Susquehanna with China opening, Apple 'de-risked' AAPL Apple $159.91 / +2.235 (+1.42%) 02/02/23 Apple reports Q1 EPS $1.88, consensus $1.94 02/02/23 Notable companies reporting after market close 10/27/22 Apple reports Q4 EPS $1.29, consensus $1.17 10/27/22 Notable companies reporting after market close AAPL Apple $159.91 / +2.235 (+1.42%) 03/27/23 Apple demos mixed reality headset for Top 100 executives, Bloomberg reports 03/24/23 Apple tracking employee attendance via badge records, says Platformer's Schiffer 03/23/23 Apple to spend $1B a year to produce theatrical releases, Bloomberg reports 03/23/23 Apple weighs bidding for English football streaming rights, Bloomberg reports AAPL Apple $159.91 / +2.235 (+1.42%) 03/27/23 What You Missed On Wall Street On Monday 03/27/23 What You Missed On Wall Street This Morning 03/24/23 What You Missed On Wall Street This Morning 03/21/23 What You Missed This Week in Video Games AAPL Apple $159.91 / +2.235 (+1.42%) 03/28/23 Notable open interest changes for March 28th 03/27/23 Notable open interest changes for March 27th 03/24/23 Notable open interest changes for March 24th 03/22/23 Notable open interest changes for March 22nd
Hot Stocks	J&J's Janssen discontinues RSV adult vaccine program » 12:46 03/29/23 03/29 12:46 03/29/23 12:46 JNJ Johnson & Johnson $152.91 / +1.14 (+0.75%) Johnson &… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options JNJ Johnson & Johnson $152.91 / +1.14 (+0.75%) 07:10 Today STAAR Surgical names Warren Foust COO, Magda Michna, as chief of medical affairs 03/22/23 Johnson & Johnson issues statement on Third Circuit review petition 03/15/23 Janssen announces publication of data on dengue antiviral candidate 03/07/23 Protagonist Therapeutics reports 'positive' results from FRONTIER 1 Phase 2b JNJ Johnson & Johnson $152.91 / +1.14 (+0.75%) 08:51 Today UBS Johnson & Johnson assumed with a Neutral at UBS 03/28/23 UBS Johnson & Johnson initiated with a Neutral at UBS 03/13/23 Stifel Arcellx initiated with a Buy at Stifel 03/01/23 Guggenheim Johnson & Johnson initiated with a Neutral, $161 price target at Guggenheim JNJ Johnson & Johnson $152.91 / +1.14 (+0.75%) 02/28/23 Fate Therapeutics reports Q4 EPS (58c), consensus (86c) 01/30/23 Johnson & Johnson to challenge federal appeals court ruling 01/24/23 Johnson & Johnson sees FY23 adjusted EPS $10.45- $10.65, consensus $10.33 01/24/23 Johnson & Johnson sees FY23 adjusted operational EPS $10.40-$10.60 JNJ Johnson & Johnson $152.91 / +1.14 (+0.75%) 02/01/23 Novavax refuses to refund $700M for COVID shots never delivered, NY Times says 01/30/23 Appeals court dismisses Chapter 11 case of J&J unit, WSJ reports 01/13/23 Johnson & Johnson cuts production of Covid-19 vaccine, WSJ reports 01/09/23 J&J may look for deals that boost eye care, surgical robots units, Reuters says JNJ Johnson & Johnson $152.91 / +1.14 (+0.75%) 03/01/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/30/23 What You Missed On Wall Street On Monday 01/30/23 What You Missed On Wall Street This Morning 01/24/23 What You Missed On Wall Street On Tuesday 04/18/23 Johnson & Johnson - JNJ 04/25/23 Johnson & Johnson 04/27/23 Johnson & Johnson JNJ Johnson & Johnson $152.91 / +1.14 (+0.75%) 03/22/23 Johnson & Johnson put volume heavy and directionally bearish 03/13/23 Unusually active option classes on open March 13th 01/31/23 Johnson & Johnson put buyer realizes 135% same-day gains 01/30/23 Johnson & Johnson put volume heavy and directionally bearish
Options	Tencent call volume above normal and directionally bullish » 12:45 03/29/23 03/29 12:45 03/29/23 12:45 TME Tencent Music $8.30 / +0.235 (+2.92%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options TME Tencent Music $8.30 / +0.235 (+2.92%) 03/21/23 Tencent Music falls -10.0% 02/08/23 Tencent Music announces integration of TME UNI Chart on Billboard's website 01/30/23 Tencent Music falls -8.2% 01/30/23 Tencent Music falls -10.0% TME Tencent Music $8.30 / +0.235 (+2.92%) 01/19/23 86 Research Tencent Music downgraded to Hold from Buy at 86 Research 12/01/22 Morgan Stanley Tencent Music upgraded at Morgan Stanley with sustainable growth ahead 12/01/22 Morgan Stanley Tencent Music upgraded to Overweight from Equal Weight at Morgan Stanley 11/22/22 JPMorgan Tencent Music upgraded to Overweight from Neutral at JPMorgan (yesterday) TME Tencent Music $8.30 / +0.235 (+2.92%) 03/21/23 Tencent Music reports Q4 EPS 11c, consensus 13c 11/15/22 Tencent Music reports Q3 EPS 12c, consensus 10c TME Tencent Music $8.30 / +0.235 (+2.92%) 03/21/23 What You Missed On Wall Street On Tuesday 03/21/23 What You Missed On Wall Street This Morning 03/21/23 Fly Intel: Pre-market Movers 12/01/22 What You Missed On Wall Street On Thursday TME Tencent Music $8.30 / +0.235 (+2.92%) 03/23/23 Tencent call volume above normal and directionally bullish 03/09/23 Tencent call volume above normal and directionally bullish 03/01/23 Tencent call volume above normal and directionally bullish 02/09/23 Tencent call volume above normal and directionally bullish
Earnings	Notable companies reporting after market close » 12:44 03/29/23 03/29 12:44 03/29/23 12:44 RH RH $243.90 / +2.78 (+1.15%) Notable companies… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options RH RH $243.90 / +2.78 (+1.15%) 02/03/23 RH says certain financial statements 'should no longer be relied upon' 02/03/23 RH sees FY22 revenue growth at low end of prior range of (3.5%)-(4.5%) 12/08/22 RH says Q3 gross margin contracted 50bps 12/08/22 RH to acquire Dmitriy & Co RH RH $243.90 / +2.78 (+1.15%) 03/27/23 Wedbush RH price target lowered to $245 from $335 at Wedbush 03/06/23 Jefferies RH cut to Hold at Jefferies with luxury housing market 'struggling to stabilize' 03/06/23 Jefferies RH downgraded to Hold from Buy at Jefferies 02/07/23 Barclays Barclays sees a 'reset' in U.S. retail but 'not a recession yet' RH RH $243.90 / +2.78 (+1.15%) 12/08/22 RH narrow FY22 revenue growth view to down 4.5% to down 3.5% 12/08/22 RH reports Q3 EPS $5.67, consensus $4.70 12/08/22 Notable companies reporting after market close RH RH $243.90 / +2.78 (+1.15%) 03/06/23 What You Missed On Wall Street On Monday 03/06/23 What You Missed On Wall Street This Morning 03/06/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/06/23 What You Missed On Wall Street On Monday 17:00 Today RH - RH RH RH $243.90 / +2.78 (+1.15%) 02/08/23 Largest borrow rate increases among liquid names 12/08/22 Restoration Hardware options imply 7.8% move in share price post-earnings 10/24/22 Restoration Hardware put volume heavy and directionally bearish
Periodicals	Carlyle, Lone Star join Apollo for Arconic bid, Dealreporter says » 12:30 03/29/23 03/29 12:30 03/29/23 12:30 ARNC Arconic $26.88 / +0.19 (+0.71%) , CG Carlyle Group $30.28 / -0.22 (-0.72%) , APO Apollo Global $59.90 / +0.79 (+1.34%) Carlyle Group (CG) and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options ARNC CG APO ARNC Arconic $26.88 / +0.19 (+0.71%) 02/28/23 Arconic trading resumes 02/28/23 Arconic jumps 10% to $24.29 after WSJ report of Apollo buyout talks 02/28/23 Arconic trading halted, volatility trading pause 02/07/23 Arconic reports $304M after-tax loss on sale of Russian operations CG Carlyle Group $30.28 / -0.22 (-0.72%) 02/09/23 Repligen appoints Martin Madaus to board of directors 02/07/23 Carlyle approves increase in common stock dividend to $1.40 annual rate 02/06/23 Carlyle Group names Harvey Schwartz as CEO, board member 02/02/23 Carlyle in talks with ex-Goldman exec Schwartz for CEO role, Semafor says APO Apollo Global $59.90 / +0.79 (+1.34%) 05:24 Today Apollo Global upsizes investment in Apollo Delos platform 03/21/23 CVR Energy to replace Atlas Air in S&P 600 at open on 3/21 03/15/23 CVR Energy to replace Atlas Air in S&P 600 at open on 3/21 03/14/23 Atlas Air expects to consummate Apollo merger on or about March 17 ARNC CG APO ARNC Arconic $26.88 / +0.19 (+0.71%) 02/28/23 Goldman Sachs Arconic downgraded to Sell from Neutral at Goldman Sachs 02/22/23 Deutsche Bank Arconic price target lowered to $21 from $23 at Deutsche Bank 01/24/23 Deutsche Bank Arconic price target raised to $23 from $22 at Deutsche Bank 12/15/22 Benchmark Arconic price target lowered to $26 from $30 at Benchmark CG Carlyle Group $30.28 / -0.22 (-0.72%) 03/02/23 Barclays Carlyle Group initiated with an Overweight at Barclays 02/08/23 Deutsche Bank Carlyle Group price target raised to $43 from $41 at Deutsche Bank 02/08/23 Piper Sandler Carlyle Group price target lowered to $48 from $58 at Piper Sandler 01/31/23 BMO Capital Franklin Resources price target raised to $23 from $22 at BMO Capital APO Apollo Global $59.90 / +0.79 (+1.34%) 03/22/23 Barclays Apollo Global price target lowered to $74 from $80 at Barclays 02/10/23 Keefe Bruyette Apollo Global upgraded to Outperform from Market Perform at Keefe Bruyette 01/31/23 BMO Capital Franklin Resources price target raised to $23 from $22 at BMO Capital 01/12/23 Barclays Apollo Global price target raised to $85 from $78 at Barclays ARNC CG APO ARNC Arconic $26.88 / +0.19 (+0.71%) 02/21/23 Arconic sees FY23 revenue $8B-$8.5B, consensus $8.47B 02/21/23 Arconic reports Q4 EPS ($2.70) with loss, consensus 28c 11/01/22 Arconic lowers FY22 revenue view to $9B-$9.3B from $9.2B-$9.5B, consensus $9.05B 11/01/22 Arconic reports Q3 EPS with impairment (64c), consensus 24c CG Carlyle Group $30.28 / -0.22 (-0.72%) 02/07/23 Carlyle Group reports Q4 distributable EPS $1.01, consensus 96c 11/08/22 Carlyle Group reports Q3 distributable EPS $1.42, consensus $1.06 APO Apollo Global $59.90 / +0.79 (+1.34%) 02/09/23 Apollo Global reports Q4 adjusted EPS $1.42, consensus $1.50 02/08/23 Notable companies reporting before tomorrow's open 02/08/23 Notable companies reporting before tomorrow's open 11/02/22 Apollo Global reports Q3 EPS ($1.52) vs. $1.01 last year ARNC CG APO ARNC Arconic $26.88 / +0.19 (+0.71%) 02/28/23 Arconic working with advisers after receiving Apollo bid, WSJ reports 02/28/23 Apollo in talks to acquire Arconic, WSJ reports 02/06/23 U.S. planning 200% tariff on Russian aluminum, Bloomberg reports 02/06/23 U.S. plans 200% tariff on Russian aluminum, Bloomberg says CG Carlyle Group $30.28 / -0.22 (-0.72%) 03/20/23 Thermo Fisher, Celltrion compete for Baxter's biopharma unit, Reuters says 03/14/23 Buyout titans weighing purchases from SVB loan book, FT reports 02/06/23 Carlyle expected to name ex-Goldman exec as CEO this week, Bloomberg reports 01/13/23 Mason, Pruzan have held talks with Carlyle for CEO role, FT reports APO Apollo Global $59.90 / +0.79 (+1.34%) 03/14/23 Buyout titans weighing purchases from SVB loan book, FT reports 03/14/23 Apollo Global agrees to buy Univar for $8.1B including debt, WSJ reports 03/13/23 Apollo Global looking at Silicon Valley Bank book of loans, Bloomberg reports 03/13/23 Apollo Global looking at Silicon Valley Bank assets, Bloomberg reports ARNC CG APO ARNC Arconic $26.88 / +0.19 (+0.71%) 03/04/23 Buy/Sell: Wall Street's top 10 stock calls this week 02/28/23 What You Missed On Wall Street On Tuesday 02/28/23 What You Missed On Wall Street This Morning 02/28/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations CG Carlyle Group $30.28 / -0.22 (-0.72%) 12/22/22 What You Missed On Wall Street On Thursday 12/22/22 What You Missed On Wall Street This Morning 11/15/22 What You Missed On Wall Street On Tuesday 11/08/22 Fly Intel: Pre-market Movers APO Apollo Global $59.90 / +0.79 (+1.34%) 03/14/23 What You Missed On Wall Street On Tuesday 03/14/23 What You Missed On Wall Street This Morning 03/14/23 Fly Intel: Pre-market Movers 03/04/23 Buy/Sell: Wall Street's top 10 stock calls this week APO APO Apollo Global $59.90 / +0.79 (+1.34%) 01/09/23 Apollo Global put volume heavy and directionally bearish 12/28/22 Apollo Global put volume heavy and directionally bearish 12/22/22 Apollo Global put volume heavy and directionally bearish 12/07/22 Apollo Global put volume heavy and directionally bearish
Syndicate	Top KingWin 3M share IPO price range $4.00-$5.00 » 12:28 03/29/23 03/29 12:28 03/29/23 12:28 TCJH Top KingWin / + Univest Securities is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Recommendations	BridgeBio likely worth $3B-$4B in takeover, says BofA » 12:27 03/29/23 03/29 12:27 03/29/23 12:27 BBIO BridgeBio $17.66 / +2.64 (+17.58%) BofA analyst Greg… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options BBIO BridgeBio $17.66 / +2.64 (+17.58%) 03/24/23 BridgeBio Pharma trading resumes 03/24/23 BridgeBio up 3%, halted for volatility after report on takeover interest 03/24/23 BridgeBio Pharma trading halted, volatility trading pause 03/23/23 BridgeBio announces first patient dosed in Phase 1 trial of BBP-398 with OPDIVO BBIO BridgeBio $17.66 / +2.64 (+17.58%) 03/07/23 BofA Ascendis Pharma has positive read-through from BridgeBio data, says BofA 03/07/23 BofA Tyra Biosciences has positive read-through from BridgeBio data, says BofA 03/07/23 BofA BridgeBio price target raised to $18 from $15 at BofA 03/06/23 Oppenheimer Opco views BridgeBio data as good news for Tyra Biosciences BBIO BridgeBio $17.66 / +2.64 (+17.58%) 02/23/23 BridgeBio reports Q4 EPS (92c), consensus (85c) 11/03/22 BridgeBio reports Q3 EPS (93c), consensus (99c) 08 Mar BBIO BridgeBio $17.66 / +2.64 (+17.58%) 03/24/23 BridgeBio attracting bigger companies' takeover interest, Bloomberg says 03/24/23 BridgeBio attracting bigger companies' takeover interest, Bloomberg says BBIO BridgeBio $17.66 / +2.64 (+17.58%) 03/08/23 What You Missed On Wall Street On Wednesday 03/08/23 What You Missed On Wall Street This Morning 03/06/23 What You Missed On Wall Street On Monday 03/06/23 What You Missed On Wall Street This Morning BBIO BridgeBio $17.66 / +2.64 (+17.58%) 10:25 Today BridgeBio Pharma call volume above normal and directionally bullish
Syndicate	Millennium Group 1.25M share IPO, expected to price at $4.00 » 12:25 03/29/23 03/29 12:25 03/29/23 12:25 MGIH Millennium Group / + Revere and R.F. Lafferty… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial

Recommendations	ProPhase Labs making progress on multiple fronts, says H.C. Wainwright » 12:25 03/29/23 03/29 12:25 03/29/23 12:25 PRPH ProPhase Labs $7.87 / -0.43 (-5.18%) H.C. Wainwright… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings PRPH ProPhase Labs $7.87 / -0.43 (-5.18%) 03/15/23 ProPhase Labs announces $6M stock repurchase program 03/13/23 ProPhase Labs announces data presentation on BE-smart Test 03/07/23 ProPhase Labs' Nebula Genomics introduces lowest NGS pricing 03/02/23 DSS ProPhase Labs announces letter to shareholders PRPH ProPhase Labs $7.87 / -0.43 (-5.18%) 11/11/22 H.C. Wainwright ProPhase Labs price target raised to $15 from $14 at H.C. Wainwright 07/21/22 Dawson James ProPhase Labs downgraded to Sell from Neutral at Dawson James 05/16/22 H.C. Wainwright ProPhase Labs price target lowered to $14 from $16 at H.C. Wainwright 03/31/22 H.C. Wainwright ProPhase Labs price target raised to $16 from $15 at H.C. Wainwright PRPH ProPhase Labs $7.87 / -0.43 (-5.18%) 03/28/23 ProPhase Labs reports 2022 EPS $1.02 vs. 40c last year 11/10/22 ProPhase Labs reports Q3 EPS 6c vs (26c) last year
Options	SunPower call volume above normal and directionally bullish » 12:25 03/29/23 03/29 12:25 03/29/23 12:25 SPWR SunPower $13.05 / +0.845 (+6.92%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options SPWR SunPower $13.05 / +0.845 (+6.92%) 03/02/23 SunPower to delay filing 10-K report 02/15/23 SunPower sees FY23 adjusted EBITDA $125M-$155M 01/10/23 RMI launches virtual power plant partnership with GM, Google, Ford 01/05/23 SunPower, Maxeon Solar extend current supply relationship SPWR SunPower $13.05 / +0.845 (+6.92%) 03/09/23 Citi SunPower initiated with a Neutral at Citi 03/02/23 Scotiabank SunPower initiated with a Sector Perform at Scotiabank 02/17/23 Deutsche Bank SunPower price target lowered to $15 from $21 at Deutsche Bank 02/16/23 JPMorgan SunPower price target lowered to $18 from $19 at JPMorgan SPWR SunPower $13.05 / +0.845 (+6.92%) 02/15/23 SunPower reports Q4 adjusted EPS 15c, consensus 13c 02/15/23 Notable companies reporting after market close 11/08/22 SunPower backs FY22 adjusted EBITDA view $90M-$110M 11/08/22 SunPower reports Q3 adjusted cont ops EPS 13c, consensus 8c SPWR SunPower $13.05 / +0.845 (+6.92%) 12/02/22 Chinese solar producers dodged U.S. tariffs, WSJ reports SPWR SunPower $13.05 / +0.845 (+6.92%) 03/13/23 What You Missed This Week in EVs and Clean Energy 02/13/23 What You Missed This Week in EVs and Clean Energy 02/09/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/30/23 Here's what Wall St. experts are saying about these automakers ahead of earnings SPWR SunPower $13.05 / +0.845 (+6.92%) 02/15/23 SunPower options imply 9.0% move in share price post-earnings 01/20/23 SunPower put volume heavy and directionally bearish 12/16/22 SunPower call volume above normal and directionally bullish 12/15/22 SunPower put volume heavy and directionally bearish
Syndicate	Chanson International 3.75M share IPO price range $4.00-$6.00 » 12:23 03/29/23 03/29 12:23 03/29/23 12:23 CHSN Chanson International / + EF Hutton is acting as… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Technical Analysis	NASDAQ market internals summary » 12:17 03/29/23 03/29 12:17 03/29/23 12:17 $NSD NASDAQ Market Internals / + Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals / + 11:17 Today NASDAQ market internals summary 10:17 Today NASDAQ market internals summary 03/28/23 NASDAQ market internals summary 03/28/23 NASDAQ market internals summary
Technical Analysis	NYSE market internals summary » 12:16 03/29/23 03/29 12:16 03/29/23 12:16 $NYE NYSE Market Internals / + Volume is average for… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals / + 11:16 Today NYSE market internals summary 10:16 Today NYSE market internals summary 03/28/23 NYSE market internals summary 03/28/23 NYSE market internals summary

Events

Earnings calls, analyst events, roadshows and more

VRNT
Today at 16:30

Verint - VRNT Conference Calls
XOS
Today at 16:30

Xos - XOS Conference Calls
DERM
Today at 16:30

Journey Medical - DERM Conference Calls
OCX
Today at 16:30

OncoCyte - OCX Conference Calls
ASNS
Today at 16:30

Actelis Networks - ASNS Conference Calls
BCDA
Today at 16:30

BioCardia - BCDA Conference Calls
SGBX
Today at 16:30

Safe & Green - SGBX Conference Calls
BEEM
Today at 16:30

Beam Global - BEEM Conference Calls
OPGN
Today at 16:30

OpGen - OPGN Conference Calls
AXDX
Today at 16:30

Accelerate Diagnostics - AXDX Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	YGF X YGF YanGuFang IPO Managers: EF Hutton Priced at: $4.00 2M Shares ZJYL X ZJYL Jin Medical IPO Managers: Prime Number Priced at: $8.00 1M Shares
Tues	HLP X HLP Hongli Group IPO Managers: EF Hutton Priced at: $4.00 2.06M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	CHSN X CHSN Chanson International IPO Managers: EF Hutton $4.00-6.00 3.75M Shares MGIH X MGIH Millennium Group IPO Managers: Revere & R.F. Lafferty $4.00 1.25M Shares TCJH X TCJH Top KingWin IPO Managers: Univest Securities $4.00-5.00 3M Shares BMEA X BMEA Biomea Fusion Secondary Managers: JPMorgan & Citi, Oppenheimer, Barclays $30.71 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	SYT X SYT Syla Technologies IPO Managers: Boustead $8.00 1.875M Shares
Fri	No deals

View All Syndicate Announcements »

Xeris Biopharma announces results of extended Recorlev study from Sonics Study

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access